Intimation is given that the 77th Annual General Meeting of Novartis India Limited is scheduled to be held on Thursday, July 31, 2025, through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has announced its 77th AGM to be held on Thursday, July 31, 2025 at 11:00 AM via Video Conferencing, in compliance with MCA and SEBI circulars. The meeting will consider adoption of audited financial statements for FY 2024-25, declaration of a final dividend of ₹25 per equity share (face value ₹5), re-appointment of Mr. Falin Majmudar as Director (retires by rotation), and appointment of M K Saraf & Associates LLP as Secretarial Auditors for a five-year term from April 1, 2025 to March 31, 2030. Remote e-voting will be open from July 28, 2025 (9:00 AM) to July 30, 2025 (5:00 PM), with a cut-off date of July 24, 2025. The Chairman's letter highlights India's projected 6.2% GDP growth, a 9.78% increase in healthcare budget to ₹99,858 crore, and the company's portfolio spanning transplant, established medicines, neurosciences, and oncology with 24 brands.
Shareholders as on record date July 23, 2025 stand to receive a ₹25 per share dividend, subject to AGM approval. The dividend payout signals consistent shareholder returns, while the AGM business items are largely procedural and unlikely to materially impact stock price. The continued ₹25 dividend level (same as FY 2023-24) suggests stable financial performance.